Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization ...lebanon

THE DAILY STAR - News
Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization
Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.

Hence then, the article about pfizer ends covid 19 trial with 95 efficacy to seek emergency use authorization was published today ( ) and is available on THE DAILY STAR ( lebanon ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News